| Literature DB >> 31841279 |
Hao-Min Cheng1,2,3, Shao-Yuan Chuang4, Tzung-Dau Wang5, Kazuomi Kario6, Peera Buranakitjaroen7, Yook-Chin Chia8,9, Romeo Divinagracia10, Satoshi Hoshide6, Huynh Van Minh11, Jennifer Nailes10, Sungha Park12, Jinho Shin13, Saulat Siddique14, Jorge Sison15, Arieska Ann Soenarta16, Guru Prasad Sogunuru17,18, Apichard Sukonthasarn19, Jam Chin Tay20, Boon Wee Teo21, Yuda Turana22, Narsingh Verma23, Yuqing Zhang24, Ji-Guang Wang25, Chen-Huan Chen1,2.
Abstract
Since noninvasive central blood pressure (BP) measuring devices are readily available, central BP has gained growing attention regarding its clinical application in the management of hypertension. The disagreement between central and peripheral BP has long been recognized. Some previous studies showed that noninvasive central BP may be better than the conventional brachial BP in association with target organ damages and long-term cardiovascular outcomes. Recent studies further suggest that the central BP strategy for confirming a diagnosis of hypertension may be more cost-effective than the conventional strategy, and guidance of hypertension management with central BP may result in less use of medications to achieve BP control. Despite the use of central BP being promising, more randomized controlled studies comparing central BP-guided therapeutic strategies with conventional care for cardiovascular events reduction are required because noninvasive central and brachial BP measures are conveniently available. In this brief review, the rationale supporting the utility of central BP in clinical practice and relating challenges are summarized.Entities:
Keywords: brachial BP; central BP; diagnosis; high BP; hypertension; management; peripheral BP
Mesh:
Substances:
Year: 2019 PMID: 31841279 PMCID: PMC8029873 DOI: 10.1111/jch.13758
Source DB: PubMed Journal: J Clin Hypertens (Greenwich) ISSN: 1524-6175 Impact factor: 3.738